We answer all these questions and more in this 5-page white paper.
About the Author
Jaap Laufer, MD, PharmD is Vice President of Regulatory & Clinical Affairs at Emergo. Dr. Laufer has over 30 years of experience in the medical device and pharmaceuticals industries. He previously held executive and senior regulatory positions at Pfizer, Abbott Laboratories, LipoMatrix, and others. His areas of expertise include a vast array of mostly implant and higher classed products, ISO and FDA QSR audits, and clinical study approvals and compliance. He holds a PharmD in Pharmacy from the University of Groningen and is an MD from the Medical School of the University of Nijmegen, both in The Netherlands. Dr. Laufer is a member of the Medical Devices Expert Group to the EU Commission and teaches at the University of Southern California in Los Angeles, USA.
自2018年起,美国食品和药物管理局(U.S. Food and Drug Administration,FDA)开始试行以电子化方式来帮助行业提供完整的510(k)上市前通知。2022年,为推进以电子格式提供510(k)递交文件的过渡,美国FDA正式发布关于使用电子递交模板和资源的最终指导文
阅读更多近年来,巴西医疗器械监管当局ANVISA频频发布新规,以求促进巴西当地医疗器械市场发展。目前巴西医疗器械上市监管环境逐渐透明化,随着新法规的不断出台及更新,许多欲开拓出海市场的医疗器械企业正把巴西作为主要目标市场之一。 然而,相较于全球诸多医疗器械市场监管环境而言,巴西市场目前仍
阅读更多